Article info
PDFClinical and epidemiological research
Extended report
A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study
- Correspondence to Dr Jakub Závada, Institute of Rheumatology, Na Slupi 4, Praha 2, 12850, Czech Republic; zavada{at}revma.cz
Citation
A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study
Publication history
- Received January 7, 2014
- Revised August 4, 2014
- Accepted August 10, 2014
- First published August 27, 2014.
Online issue publication
August 10, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/